Equipment Supplement: Understanding the Cellular Basis of Movement Disorders
设备补充:了解运动障碍的细胞基础
基本信息
- 批准号:10755946
- 负责人:
- 金额:$ 1.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-15 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAdultAffectAgonistAlzheimer&aposs DiseaseAstrocytesAtaxiaAutopsyBehavior assessmentBrainCAG repeatCannabinoidsCellsCerebellar CortexCerebellar degenerationCerebellumDataDefectDevelopmentDevelopmental ProcessDiseaseDisease ProgressionElectrophysiology (science)EquipmentEventFunctional disorderGeneticGenetic TranscriptionHumanHuntington DiseaseImpairmentInterneuronsLifeModelingMovement DisordersMusMyoepithelial cellNerve DegenerationNeurodegenerative DisordersNeuronsNeurotransmittersParkinson DiseasePathogenicityPathologicPathologyPatientsPhenotypePlayPopulationProcessProliferatingProteinsPurkinje CellsResistanceRoleSeizuresSonic Hedgehog PathwayStimulation of Cell ProliferationSystemTestingTherapeuticTimeToxic effectTrinucleotide Repeat ExpansionType 1 Spinocerebellar AtaxiaWild Type Mouseataxin-1autosomebehavior testcyclopamineendogenous cannabinoid systemexperimental studygain of functiongamma-Aminobutyric Acidinhibitorknock-downmutantnetwork dysfunctionneuroprotectionoverexpressionpharmacologicpolyglutaminepostnatalpreclinical trialpresynapticpreventreceptorsonic hedgehog receptorstellate cellstem cell nichestem cell populationstem cellstherapeutic targettranscriptomicstransmission process
项目摘要
Project Summary
Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disease caused by a CAG
trinucleotide repeat expansion in ATXN1 that leads to an abnormally long polyglutamine tract in the
subsequent protein, ataxin-1 (ATXN1). Mutant ATXN1 has a propensity to misfold, resist cellular degradation,
and increase in toxicity as its levels rise. This toxicity occurs by a gain of function mechanism with evidence
point to transcriptional derangements as an early, presymptomatic pathogenic event. We recently discovered
that the earliest abnormalities in Purkinje cells (cells that are most vulnerable in SCA1) are not caused by cell-
autonomous changes but in a non-cell autonomous manner by affecting the proliferation and fate of cerebellar
post-natal stem cells. In this proposal, we will test the hypothesis that the underlying SCA1 pathology has its
roots in early developmental processes and that if these defects are overcome one might be able to delay or
ameliorate later neurodegeneration, thus paving the way for therapy for this currently untreatable condition.
项目摘要
1型脊髓脑性共济失调(SCA1)是由CAG引起的常染色体显性神经退行性疾病
三核苷酸重复膨胀在ATXN1中导致异常长的聚谷氨酰胺道
随后的蛋白质,共生1(ATXN1)。突变ATXN1具有错误折叠的倾向,抵抗细胞降解,
并随着其水平上升而增加毒性。这种毒性是通过获得证据的功能机制而发生的
指向转录毁灭作为早期的,症状的病原事件。我们最近发现
浦肯野细胞中最早的异常(SCA1中最脆弱的细胞)不是由细胞引起的
自主变化,但通过影响小脑的增殖和命运,以非细胞自主的方式
产后干细胞。在该提议中,我们将检验以下假设,即潜在的SCA1病理具有
根源在早期发展过程中,如果克服这些缺陷,可能会延迟或
改善后来的神经退行性,从而为这种目前不可治疗的疾病铺平了治疗的道路。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
An investigation of diffusion imaging techniques in the evaluation of spinocerebellar ataxia and multisystem atrophy.
- DOI:10.1016/j.jocn.2014.08.006
- 发表时间:2015-01
- 期刊:
- 影响因子:0
- 作者:Rozenfeld MN;Nemeth AJ;Walker MT;Mohan P;Wang X;Parrish TB;Opal P
- 通讯作者:Opal P
The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAP.
- DOI:10.1091/mbc.e16-06-0362
- 发表时间:2016-12-15
- 期刊:
- 影响因子:3.3
- 作者:Lin NH;Huang YS;Opal P;Goldman RD;Messing A;Perng MD
- 通讯作者:Perng MD
Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1.
- DOI:10.1007/s12311-016-0794-9
- 发表时间:2017-04
- 期刊:
- 影响因子:0
- 作者:Cvetanovic M;Hu YS;Opal P
- 通讯作者:Opal P
Developmental Alterations in Adult-Onset Neurodegenerative Disorders: Lessons from Polyglutamine Diseases.
- DOI:10.1002/mds.28657
- 发表时间:2021-07
- 期刊:
- 影响因子:8.6
- 作者:Edamakanti, Chandrakanth Reddy;Opal, Puneet
- 通讯作者:Opal, Puneet
The promise and perils of HDAC inhibitors in neurodegeneration.
- DOI:10.1002/acn3.147
- 发表时间:2015-01
- 期刊:
- 影响因子:5.3
- 作者:Didonna, Alessandro;Opal, Puneet
- 通讯作者:Opal, Puneet
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Puneet Opal其他文献
Puneet Opal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Puneet Opal', 18)}}的其他基金
VEGF-Mimetic Supramolecular Nanoparticles for Treating Spinocerebellar Ataxia Type 1
VEGF 模拟超分子纳米颗粒用于治疗 1 型脊髓小脑共济失调
- 批准号:
10578485 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Elucidating cellular mechanisms underlying neurodegeneration
阐明神经变性的细胞机制
- 批准号:
10647869 - 财政年份:2022
- 资助金额:
$ 1.86万 - 项目类别:
Elucidating cellular mechanisms underlying neurodegeneration
阐明神经变性的细胞机制
- 批准号:
10435954 - 财政年份:2022
- 资助金额:
$ 1.86万 - 项目类别:
Developing novel treatment strategies for Spinocerebellar ataxia type 1
开发 1 型脊髓小脑共济失调的新治疗策略
- 批准号:
9226821 - 财政年份:2016
- 资助金额:
$ 1.86万 - 项目类别:
Understanding the cellular basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
8876831 - 财政年份:2013
- 资助金额:
$ 1.86万 - 项目类别:
Understanding the cellular basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
8631893 - 财政年份:2013
- 资助金额:
$ 1.86万 - 项目类别:
Understanding the Cellular Basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
10630308 - 财政年份:2013
- 资助金额:
$ 1.86万 - 项目类别:
Understanding the Cellular Basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
10403448 - 财政年份:2013
- 资助金额:
$ 1.86万 - 项目类别:
Understanding the cellular basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
8719191 - 财政年份:2013
- 资助金额:
$ 1.86万 - 项目类别:
Understanding the Cellular Basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
10160963 - 财政年份:2013
- 资助金额:
$ 1.86万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
- 批准号:
10748776 - 财政年份:2024
- 资助金额:
$ 1.86万 - 项目类别:
In vivo feasibility of a smart needle ablation treatment for liver cancer
智能针消融治疗肝癌的体内可行性
- 批准号:
10699190 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome
什瓦赫曼-戴蒙德综合征应激反应的基因剖析
- 批准号:
10594366 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
LRP1 作为成体神经干细胞和中风后反应中 CXCR4 的新型调节剂
- 批准号:
10701231 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Elucidating signaling networks in Anterior Segment development, repair and diseases
阐明眼前节发育、修复和疾病中的信号网络
- 批准号:
10718122 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别: